유방암종에서 Vascular Endothelial Growth Factor-C 발현
Expression of Vascular Endothelial Growth Factor-C in Breast Carcinoma
정명자, 장규윤, 이동근, 강명재, 양선호, 문우성,
소속 상세정보
정명자 ( Chung Myoung-Ja )
전북대학교 의과대학 병리학교실
장규윤 ( Jang Kyu-Yun )
전북대학교 의과대학 병리학교실
이동근 ( Lee Dong-Geun )
전북대학교 의과대학 병리학교실
강명재 ( Kang Myoung-Jae )
전북대학교 의과대학 병리학교실
양선호 ( Yang Sun-Ho )
전북대학교 의과대학 재활의학교실
문우성 ( Moon Woo-Sung )
전북대학교 의과대학 병리학교실
KMID : 0357920050390060401
Abstract
Background: Vascular endothelial growth factor-C (VEGF-C) is a novel growth factor that regulates lymphangiogenesis and/or angiogenesis via binding to the vascular endothelial growth factor receptor-3 (VEGFR-3) or VEGFR-2. Recent studies have suggested that VEGF-C may play a role in lymph node metastasis. This study was conducted to examine whether the expression of VEGF-C is associated with the clinicopathologic parameters, and especially lymph node metastasis, of invasive ductal carcinoma.
Methods: Immunohistochemical staining was performed for VEGF-C and CD31 in the surgically resected specimens from 83 patients with invasive breast carcinoma.
Results: Of the 83 breast carcinomas, 61 (74%) cases showed cytoplasmic VEGF-C immunoreactivity. VEGF-C expression was associated with lymph node metastasis (p=0.03), but it did not correlate with tumor size, the histologic grade, and the presence of estrogen receptor or progesteron receptor. The mean microvessel density in the cases without VEGF-C expression was 51.9±30.1 and it was 72.9±33.0 in the cases with 2+ expression for VEGF-C (p=0.07).
Conclusions: This study suggests that VEGF-C expression may have an association with lymph node metastasis in the patients with breast carcinoma.
키워드
Breast Carcinoma;VEGF-C
원문 및 링크아웃 정보
등재저널 정보